Viewing Study NCT00623103


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-04 @ 9:25 AM
Study NCT ID: NCT00623103
Status: COMPLETED
Last Update Posted: 2011-11-28
First Post: 2008-02-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CENA713B2315
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators